Humira Buyers Get Backing Against AbbVie's 'Patent Thicket'
By Bryan Koenig · October 13, 2020, 9:09 PM EDT
Consumer advocates, academics and a drug store industry group all have urged the Seventh Circuit to revive a lawsuit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant Humira...
To view the full article, register now.